BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38546822)

  • 1. Transcutaneous vagal nerve stimulation for treating gastrointestinal symptoms in individuals with diabetes: a randomised, double-blind, sham-controlled, multicentre trial.
    Kornum DS; Bertoli D; Kufaishi H; Wegeberg AM; Okdahl T; Mark EB; Høyer KL; Frøkjær JB; Brock B; Krogh K; Hansen CS; Knop FK; Brock C; Drewes AM
    Diabetologia; 2024 Jun; 67(6):1122-1137. PubMed ID: 38546822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study protocol for a multicentre, randomised, parallel group, sham-controlled clinical trial investigating the effect of transcutaneous vagal nerve stimulation on gastrointestinal symptoms in people with diabetes complicated with diabetic autonomic neuropathy: the DAN-VNS Study.
    Okdahl T; Bertoli D; Brock B; Krogh K; Krag Knop F; Brock C; Drewes AM
    BMJ Open; 2021 Jan; 11(1):e038677. PubMed ID: 33408197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical transcutaneous vagal neuromodulation in chronic pancreatitis patients with chronic pain: A randomised sham controlled clinical trial.
    Muthulingam JA; Olesen SS; Hansen TM; Brock C; Drewes AM; Frøkjær JB
    PLoS One; 2021; 16(2):e0247653. PubMed ID: 33635894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcutaneous noninvasive vagus nerve stimulation (tVNS) in the treatment of schizophrenia: a bicentric randomized controlled pilot study.
    Hasan A; Wolff-Menzler C; Pfeiffer S; Falkai P; Weidinger E; Jobst A; Hoell I; Malchow B; Yeganeh-Doost P; Strube W; Quast S; Müller N; Wobrock T
    Eur Arch Psychiatry Clin Neurosci; 2015 Oct; 265(7):589-600. PubMed ID: 26210303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcutaneous vagal nerve stimulation improves gastroenteric complaints in Parkinson's disease patients.
    Kaut O; Janocha L; Weismüller TJ; Wüllner U
    NeuroRehabilitation; 2019 Dec; 45(4):449-451. PubMed ID: 31868695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of transcutaneous vagus nerve stimulation in individuals aged 55 years or above: potential benefits of daily stimulation.
    Bretherton B; Atkinson L; Murray A; Clancy J; Deuchars S; Deuchars J
    Aging (Albany NY); 2019 Jul; 11(14):4836-4857. PubMed ID: 31358702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcutaneous Vagus Nerve Stimulation (tVNS) for Treatment of Drug-Resistant Epilepsy: A Randomized, Double-Blind Clinical Trial (cMPsE02).
    Bauer S; Baier H; Baumgartner C; Bohlmann K; Fauser S; Graf W; Hillenbrand B; Hirsch M; Last C; Lerche H; Mayer T; Schulze-Bonhage A; Steinhoff BJ; Weber Y; Hartlep A; Rosenow F; Hamer HM
    Brain Stimul; 2016; 9(3):356-363. PubMed ID: 27033012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal symptom burden in diabetic autonomic and peripheral neuropathy - A Danes cohort study.
    Kufaishi H; Mizrak HI; Brock B; Hansen TW; Rossing P; Hansen CS
    J Diabetes Complications; 2024 May; 38(5):108745. PubMed ID: 38615421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motivational nondirective resonance breathing versus transcutaneous vagus nerve stimulation in the treatment of fibromyalgia: study protocol for a randomized controlled trial.
    Paccione CE; Diep LM; Stubhaug A; Jacobsen HB
    Trials; 2020 Sep; 21(1):808. PubMed ID: 32967704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and feasibility of transcutaneous vagus nerve stimulation in mild cognitive impairment: VINCI-AD study protocol.
    Dolphin H; Dyer AH; Dukelow T; Finucane C; Commins S; Kennelly SP
    BMC Neurol; 2023 Aug; 23(1):289. PubMed ID: 37532979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcutaneous auricular vagus nerve stimulation to acutely reduce emotional vulnerability and improve emotional regulation in borderline personality disorder (tVNS-BPD): study protocol for a randomized, single-blind, sham-controlled trial.
    Guerriero G; Liljedahl SI; Carlsen HK; López Muñoz M; Daros AR; Ruocco AC; Steingrimsson S
    Trials; 2024 Jun; 25(1):397. PubMed ID: 38898522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal symptoms and cardiac vagal tone in type 1 diabetes correlates with gut transit times and motility index.
    Wegeberg AL; Brock C; Ejskjaer N; Karmisholt JS; Jakobsen PE; Drewes AM; Brock B; Farmer AD
    Neurogastroenterol Motil; 2021 Jan; 33(1):e13885. PubMed ID: 32573076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meditative-based diaphragmatic breathing vs. vagus nerve stimulation in the treatment of fibromyalgia-A randomized controlled trial: Body vs. machine.
    Paccione CE; Stubhaug A; Diep LM; Rosseland LA; Jacobsen HB
    Front Neurol; 2022; 13():1030927. PubMed ID: 36438970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open-label pilot study: Non-invasive vagal nerve stimulation improves symptoms and gastric emptying in patients with idiopathic gastroparesis.
    Gottfried-Blackmore A; Adler EP; Fernandez-Becker N; Clarke J; Habtezion A; Nguyen L
    Neurogastroenterol Motil; 2020 Apr; 32(4):e13769. PubMed ID: 31802596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A two-week course of transcutaneous vagal nerve stimulation improves global sleep: Findings from a randomised trial in community-dwelling adults.
    Jackowska M; Koenig J; Vasendova V; Jandackova VK
    Auton Neurosci; 2022 Jul; 240():102972. PubMed ID: 35364413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early cortical biomarkers of longitudinal transcutaneous vagus nerve stimulation treatment success in depression.
    Fang J; Egorova N; Rong P; Liu J; Hong Y; Fan Y; Wang X; Wang H; Yu Y; Ma Y; Xu C; Li S; Zhao J; Luo M; Zhu B; Kong J
    Neuroimage Clin; 2017; 14():105-111. PubMed ID: 28180068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive vagus nerve stimulation acutely improves spontaneous cardiac baroreflex sensitivity in healthy young men: A randomized placebo-controlled trial.
    Antonino D; Teixeira AL; Maia-Lopes PM; Souza MC; Sabino-Carvalho JL; Murray AR; Deuchars J; Vianna LC
    Brain Stimul; 2017; 10(5):875-881. PubMed ID: 28566194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying acute physiological biomarkers of transcutaneous cervical vagal nerve stimulation in the context of psychological stress.
    Gurel NZ; Huang M; Wittbrodt MT; Jung H; Ladd SL; Shandhi MMH; Ko YA; Shallenberger L; Nye JA; Pearce B; Vaccarino V; Shah AJ; Bremner JD; Inan OT
    Brain Stimul; 2020; 13(1):47-59. PubMed ID: 31439323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel plantar stimulation technology for improving protective sensation and postural control in patients with diabetic peripheral neuropathy: a double-blinded, randomized study.
    Najafi B; Crews RT; Wrobel JS
    Gerontology; 2013; 59(5):473-80. PubMed ID: 23860103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons learned from transcutaneous vagus nerve stimulation (tVNS).
    Hamer HM; Bauer S
    Epilepsy Res; 2019 Jul; 153():83-84. PubMed ID: 30952581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.